Irene Pecora

464 total citations
24 papers, 207 citations indexed

About

Irene Pecora is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Irene Pecora has authored 24 papers receiving a total of 207 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Irene Pecora's work include Pancreatic and Hepatic Oncology Research (6 papers), Cancer Genomics and Diagnostics (5 papers) and Gastric Cancer Management and Outcomes (5 papers). Irene Pecora is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Cancer Genomics and Diagnostics (5 papers) and Gastric Cancer Management and Outcomes (5 papers). Irene Pecora collaborates with scholars based in Italy and United Kingdom. Irene Pecora's co-authors include Lorenzo Fornaro, Caterina Vivaldi, Francesca Salani, Enrico Vasile, Alfredo Falcone, Silvia Catanese, Monica Lencioni, Valentina Massa, Giuseppe Aprile and Mario Clerico and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and British Journal of Cancer.

In The Last Decade

Irene Pecora

21 papers receiving 206 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Irene Pecora Italy	9	130	99	75	32	32	24	207
Yoshiki Horie Japan	7	180 1.4×	161 1.6×	103 1.4×	24 0.8×	26 0.8×	30	266
Mustafa Karaağaç Türkiye	8	142 1.1×	69 0.7×	55 0.7×	33 1.0×	47 1.5×	51	229
Tadayoshi Hashimoto Japan	10	95 0.7×	170 1.7×	161 2.1×	28 0.9×	38 1.2×	39	277
Haifu Wu China	8	91 0.7×	65 0.7×	94 1.3×	26 0.8×	17 0.5×	15	204
Kazuto Shibuya Japan	10	139 1.1×	84 0.8×	127 1.7×	68 2.1×	54 1.7×	52	273
Hajime Ushigome Japan	10	113 0.9×	94 0.9×	106 1.4×	35 1.1×	26 0.8×	30	225
Suguru Maruyama Japan	9	76 0.6×	81 0.8×	108 1.4×	68 2.1×	55 1.7×	55	232
Cristina Morelli Italy	8	125 1.0×	53 0.5×	54 0.7×	34 1.1×	37 1.2×	23	201
Tomoyuki Minami Japan	12	195 1.5×	100 1.0×	191 2.5×	65 2.0×	43 1.3×	31	343
Satoshi Shinya Japan	10	84 0.6×	82 0.8×	102 1.4×	35 1.1×	22 0.7×	17	237

Countries citing papers authored by Irene Pecora

Since Specialization

Citations

This map shows the geographic impact of Irene Pecora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irene Pecora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irene Pecora more than expected).

Fields of papers citing papers by Irene Pecora

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irene Pecora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irene Pecora. The network helps show where Irene Pecora may publish in the future.

Co-authorship network of co-authors of Irene Pecora

This figure shows the co-authorship network connecting the top 25 collaborators of Irene Pecora. A scholar is included among the top collaborators of Irene Pecora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irene Pecora. Irene Pecora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pecora, Irene, Clara Ugolini, Riccardo Giannini, et al.. (2023). Dynamic Profiling of the Immune Tumor Microenvironment in Locally Advanced Gastric Cancer Treated with Perioperative Chemotherapy. Oncology. 101(7). 435–445.

Salani, Francesca, Andrea Casadei‐Gardini, Lorenzo Fornaro, et al.. (2022). Predictive Significance of Circulating Histones in Hepatocellular Carcinoma Patients Treated with Sorafenib. Epigenomics. 14(9). 507–517. 8 indexed citations

Fornaro, Lorenzo, Gianna Musettini, Paola Orlandi, et al.. (2022). Early increase of plasma soluble VEGFR-2 is associated with clinical benefit from second-line treatment of paclitaxel and ramucirumab in advanced gastric cancer.. PubMed. 12(7). 3347–3356. 5 indexed citations

Moretto, Roberto, Daniele Rossini, Iolanda Capone, et al.. (2021). Rationale and Study Design of the PARERE Trial: Randomized phase II Study of Panitumumab Re-Treatment Followed by Regorafenib Versus the Reverse Sequence in RAS and BRAF Wild-Type Chemo-Refractory Metastatic Colorectal Cancer Patients. Clinical Colorectal Cancer. 20(4). 314–317. 12 indexed citations

Catanese, Silvia, Giacomo Aringhieri, Caterina Vivaldi, et al.. (2021). Role of Baseline Computed-Tomography-Evaluated Body Composition in Predicting Outcome and Toxicity from First-Line Therapy in Advanced Gastric Cancer Patients. Journal of Clinical Medicine. 10(5). 1079–1079. 15 indexed citations

Vivaldi, Caterina, Stefania Crucitta, Silvia Catanese, et al.. (2021). Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel. The Pharmacogenomics Journal. 21(2). 233–242. 11 indexed citations

Vivaldi, Caterina, Lorenzo Fornaro, Clara Ugolini, et al.. (2020). HER2 Overexpression as a Poor Prognostic Determinant in Resected Biliary Tract Cancer. The Oncologist. 25(10). 886–893. 39 indexed citations

Salani, Francesca, Irene Pecora, Caterina Vivaldi, et al.. (2020). P-219 Clear cell variant of hepatocellular carcinoma (HCC-CC): A single-center observational study of an uncommon subtype. Annals of Oncology. 31. S161–S162.

Vivaldi, Caterina, Francesca Salani, Giulia Rovesti, et al.. (2020). First-line gemcitabine plus nab-paclitaxel for elderly patients with metastatic pancreatic cancer: Crossing the frontier of age?. European Journal of Cancer. 137. 108–116. 11 indexed citations

10.

Vivaldi, Caterina, Silvia Catanese, Valentina Massa, et al.. (2020). Immune Checkpoint Inhibitors in Esophageal Cancers: Are We Finally Finding the Right Path in the Mist?. International Journal of Molecular Sciences. 21(5). 1658–1658. 21 indexed citations

11.

Fornaro, Lorenzo, Caterina Vivaldi, Paola Orlandi, et al.. (2019). Longitudinal evaluation of angiogenesis-related circulating biomarkers during second-line treatment with paclitaxel and ramucirumab in advanced gastroesophageal cancer. Annals of Oncology. 30. iv88–iv88. 1 indexed citations

12.

Pasquini, G., Liliane E. Petrini, Ramon Castellana, et al.. (2019). P1.15-10 Trabectedin Has Limited Clinical Activity in Pretreated Patients with Pleural Mesothelioma. Journal of Thoracic Oncology. 14(10). S583–S584.

13.

Catanese, Silvia, Giacomo Aringhieri, Carla Cappelli, et al.. (2019). Baseline computed-tomography (CT)-evaluated sarcopenia predicts toxicity from first-line chemotherapy in metastatic gastric cancer (mGC) patients. Annals of Oncology. 30. iv82–iv82. 1 indexed citations

14.

Marisi, Giorgia, Vincenzo Dadduzio, Luca Ielasi, et al.. (2019). Multicentric prospective study of validation of angiogenesis-related gene polymorphisms in hepatocellular carcinoma patients treated with sorafenib: results of INNOVATE study. Annals of Oncology. 30. iv113–iv113. 1 indexed citations

15.

Fornaro, Lorenzo, Caterina Vivaldi, Clara Ugolini, et al.. (2019). Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer. British Journal of Cancer. 120(5). 522–526. 10 indexed citations

16.

Vivaldi, Caterina, Lorenzo Fornaro, Carla Cappelli, et al.. (2019). Early Tumor Shrinkage and Depth of Response Evaluation in Metastatic Pancreatic Cancer Treated with First Line Chemotherapy: An Observational Retrospective Cohort Study. Cancers. 11(7). 939–939. 13 indexed citations

17.

Casadei‐Gardini, Andrea, Giorgia Marisi, Vincenzo Dadduzio, et al.. (2019). Multicentric prospective study of validation of angiogenesis-related gene polymorphisms in HCC patients treated with sorafenib: Final results of INNOVATE study. Annals of Oncology. 30. v287–v287. 1 indexed citations

18.

Montagnani, Francesca, Giuseppe Aprile, Caterina Vivaldi, et al.. (2018). Long-term survival after liver metastasectomy in gastric cancer: Systematic review and meta-analysis of prognostic factors. Cancer Treatment Reviews. 69. 11–20. 44 indexed citations

19.

Vivaldi, Caterina, E. Arrigoni, Riccardo Morganti, et al.. (2017). Analysis of DPYD and UGT1A1 genotype in patients with advanced pancreatic cancer treated with modified FOLFIRINOX. Annals of Oncology. 28. vi48–vi48. 1 indexed citations

20.

Vivaldi, Caterina, Enrico Vasile, Chiara Caparello, et al.. (2016). PD-022 FOLFOXIRI as primary treatment for locally advanced unresectable pancreatic cancer (LAPC): a prospective study. Annals of Oncology. 27. ii109–ii109. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact